Functional Autoantibodies Targeting G-Protein-Coupled Receptors and Their Clinical Phenotype in Patients with Long-COVID
International Journal of Molecular Sciences · 14.07.2025 · 26 (14) · 6746
DOI: 10.3390/ijms26146746 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.07.2025. Verfasst von Sophia Hofmann und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany. Hauptthemen laut MEDLINE: Autoantibodies, Receptors, G-Protein-Coupled, COVID-19. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Federal Ministry of Research, Technology and Space (BMFTR): reCOVer, iIMMUNE_ACS, Bavarian Health and Food Safety Authority (LGL): discover.
Abstract (Originalsprache)
Long-COVID (LC) is characterized by diverse and persistent symptoms, potentially mirroring different molecular pathways. Recent data might offer that one of them is mediated by functional autoantibodies (fAAb) targeting G protein-coupled receptors (GPCR). Thus, the aim of this study was to investigate the clinical phenotype of patients with LC in relation to their GPCR-fAAb seropositivity. The present study recruited 194 patients with LC and profiled them based on self-reported symptoms. GPCR-fAAb seropositivity was identified by using a cardiomyocyte bioassay, testing the presence and functionality of the AAbs. Logistic regression, clustering, and decision tree analyses were applied to examine associations between GPCR-fAAb profiles and self-reported symptoms considering age and gender. The most prevalent GPCR-fAAbs in patients with LC were fAAB targeting the β2 adrenergic receptor (β2-fAAb, 92.8%), the muscarinergic M2 receptor (M2-fAAb, 87.1%), the Angiotensin II type 1 receptor (AT1-fAAb, 85.6%), and angiotensin (1–7) Mas receptor (MAS-fAAb, 85.6%). β2-fAAb showed a significant relation with dizziness, lack of concentration, and POTS, while Endothelin Type A receptor functional autoantibody (ET-A-fAAb) was significantly related to deterioration of pre-existing neurological disorders. Statistical analysis indicated a strong positive correlation between M2- and β2-fAAb; as in addition, an association of β2-fAAb and gender was observed to one of the major clinical symptoms (fatigue/PEM), a critical impact of GPCR-fAAb on LC-pathogenesis can be assumed. Summing up, the present data show that specific GPCR-fAAb are associated with distinct clinical phenotypes. Especially, the combination of M2- and β2-fAAb seemed to be essential for the LC-phenotype with a combination of fatigue/PEM and lack of concentration as major clinical symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
- Research Unit Analytical BioGeoChemistry, Helmholtz Zentrum München-German Research Center for Environmental Health, 85764 Neuherberg, Germany.
- Berlin Cures GmbH, 13125 Berlin, Germany.
- Rheumatology and Immunology Section, Department of Internal Medicine 3, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
- Deutsches Zentrum für Immuntherapie (DZI), Universität of Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
- Infectious Disease and Immunodeficiency Section, Department of Internal Medicine 3, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
ORCID-Profile: Sophia Hofmann, Juergen Rech, Thomas Harrer, Bettina Hohberger
Förderung
- German Federal Ministry of Research, Technology and Space (BMFTR): reCOVer
- iIMMUNE_ACS
- Bavarian Health and Food Safety Authority (LGL): discover
- German Federal Ministry of Research, Technology and Space
- Bavarian Health and Food Safety Authority
Zitieren
APA
Hofmann, S., Lucio, M., Wallukat, G., Hoffmanns, J., Schröder, T., Raith, F., Szewczykowski, C., Skornia, A., Rech, J., Schottenhamml, J., Harrer, T., Ganslmayer, M., Mardin, C., Flecks, M., Lakatos, P., & Hohberger, B. (2025). Functional Autoantibodies Targeting G-Protein-Coupled Receptors and Their Clinical Phenotype in Patients with Long-COVID. International Journal of Molecular Sciences, 26(14), 6746. https://doi.org/10.3390/ijms26146746
Vancouver
Hofmann S, Lucio M, Wallukat G, Hoffmanns J, Schröder T, Raith F, et al. Functional Autoantibodies Targeting G-Protein-Coupled Receptors and Their Clinical Phenotype in Patients with Long-COVID. International Journal of Molecular Sciences. 2025;26(14):6746. doi:10.3390/ijms26146746
BibTeX
@article{Hofmann2025,
author = {Hofmann, Sophia and Lucio, Marianna and Wallukat, Gerd and Hoffmanns, Jakob and Schröder, Thora and Raith, Franziska and Szewczykowski, Charlotte and Skornia, Adam and Rech, Juergen and Schottenhamml, Julia and Harrer, Thomas and Ganslmayer, Marion and Mardin, Christian and Flecks, Merle and Lakatos, Petra and Hohberger, Bettina},
title = {Functional Autoantibodies Targeting G-Protein-Coupled Receptors and Their Clinical Phenotype in Patients with Long-COVID},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {14},
pages = {6746},
doi = {10.3390/ijms26146746}
}
EUVIMED